FindTrial
Sign In

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Prevalence and Incidence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00224276
Enrollment
100
Registered
2005-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2005-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Diabetes Mellitus, Schizophrenia

Brief summary

This pilot study hypothesizes that diagnosed and undiagnosed prevalence of diabetes mellitus may differ across antipsychotioc medications in a community mental health center. The study further hypothesizes that control of diabetes among diagnosed cases may be suboptimal.

Detailed description

Study of longitudinal incidence proved impractical within the limitations of the project.

Interventions

None listed

Sponsors

Janssen Pharmaceutica N.V., Belgium
CollaboratorINDUSTRY
Yale University
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients treated with antipsychotic medication at a community mental health center

Exclusion criteria

* None

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026